Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | GAA | P10253 | 3/20 | 0.52 |
| ▸ | NAT1 | P18440 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | CISD1 | Q9NZ45 | 2/20 | 0.50 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.50 |
| ▸ | MMP2 | P08253 | 2/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | ALPL | P05186 | 1/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | ALPG | P10696 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15304596 | 0.86 | MYC (0.46) | ALDH1A1GAANAT1MEN1POLB | |
| SCHEMBL15101830 | 0.83 | PIM1 (0.54) | GAANAT1MEN1POLBKMT2A | |
| SCHEMBL15097021 | 0.76 | MYC (0.51) | ALDH1A1GAANAT1MEN1POLB | |
| SCHEMBL9428429 | 0.76 | PTGS2 (0.56) | ALDH1A1GAANAT1MEN1POLB | |
| SCHEMBL9428425 | 0.76 | PTGS2 (0.56) | ALDH1A1GAANAT1MEN1POLB | |
| SCHEMBL265234 | 0.70 | — | — | |
| SCHEMBL8358185 | 0.70 | — | — | |
| SCHEMBL15989509 | 0.70 | — | — | |
| SCHEMBL8167434 | 0.70 | PIM1 (0.75) | NAT1CISD1HPGDNPC1MAOA | |
| SCHEMBL8167436 | 0.70 | PIM1 (0.75) | NAT1CISD1HPGDNPC1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2541329-A1 | CHARGE CONTROLLING AGENT AND TONER USING SAME | Hodogaya Chemical Co., Ltd. (JP) | 2013-01-02 | — | — | EP | disclosed |
| US-20120315576-A1 | CHARGE CONTROLLING AGENT AND TONER USING SAME | HODOGAYA CHEMICAL CO., LTD. (JP) | 2012-12-13 | — | — | US | disclosed |
| US-20120315576-A1 | CHARGE CONTROLLING AGENT AND TONER USING SAME | HODOGAYA CHEMICAL CO., LTD. (JP) | 2012-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120315576-A1 | CHARGE CONTROLLING AGENT AND TONER USING SAME | NPY1R, HCRTR1, CCKAR | ALDH1A1 4635/4885GAA 1140/4885NAT1 1604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.